Skip to main content
. Author manuscript; available in PMC: 2015 May 2.
Published in final edited form as: J Nucl Med. 2014 May 19;55(7):1047–1053. doi: 10.2967/jnumed.113.136044

TABLE 1.

Patient and Disease Characteristics at Time of Radioimmunotherapy (n = 39)

Characteristic n or value
Age (y)
 Median 54
 Range 33–81
Male sex 29 (74)
Histology
Indolent* 31 (79)
Transformed (diffuse large B cell) 8 (21)
Stage of disease
 I 4 (11)
 II 14 (37)
 III 11 (29)
 IV 9 (24)
Chemotherapy refractory 22 (56)
No. of prior chemotherapy regimens
 Median 1
 Range 1–5
Bone marrow involvement
 0% 26 (68)
 1%–25% 12 (32)
No. of tumor sites
 Median 3
 Range 1–7
Presence of bulky disease§ 10 (26)
High lactate dehydrogenase 12 (31)
*

30 follicular, 1 marginal zone. Of the patients with follicular lymphoma, 26 were grade 1 or 2 and 4 were grade 3.

1 unknown.

Chemotherapy or rituximab.

§

At least 1 tumor with diameter more than 7 cm.

Data in parentheses are percentages.